Impact Partnership Wealth’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$921K Buy
2,618
+222
+9% +$79.1K 0.11% 129
2025
Q4
$784K Buy
2,396
+240
+11% +$76.1K 0.1% 136
2025
Q3
$608K Buy
2,156
+225
+12% +$65.3K 0.09% 140
2025
Q2
$539K Buy
+1,931
New +$547K 0.1% 128
2024
Q2
Sell
-9
Closed -$2.6K 235
2024
Q1
$2.6K Sell
9
-105
-92% -$30.7K ﹤0.01% 561
2023
Q4
$33K Sell
114
-2,746
-96% -$748K 0.01% 371
2023
Q3
$769K Buy
2,860
+2,694
+1,623% +$672K 0.24% 47
2023
Q2
$36.9K Buy
+166
New +$38.5K 0.01% 283

Other funds holding AMGN

Impact Partnership Wealth's AMGN Position: Q1 2026 in Review

Impact Partnership Wealth increased its Amgen (AMGN) stake by 9.3% in Q1 2026, buying an estimated $79.1K and bringing the position to 2,618 shares worth $921K. The position accounts for 0.11% of the portfolio, ranked #129.

Impact Partnership Wealth first reported a position in AMGN in Q2 2023 and has held it in 8 quarters since. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Impact Partnership Wealth held 2,618 shares of Amgen worth $921K as of Q1 2026.
  • Impact Partnership Wealth bought 222 Amgen shares in Q1 2026, an estimated $79.1K.
  • Amgen made up 0.11% of Impact Partnership Wealth's portfolio in Q1 2026, its #129 holding.
  • Impact Partnership Wealth first reported a position in Amgen in Q2 2023 and has held it in 8 quarters since.
  • 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Impact Partnership Wealth's 13F filing for Q1 2026, filed 23 Apr 2026.